Inactive Instrument

Calendar Galapagos NV Euronext Bruxelles

Stocks

GLPG

BE0003818359

Biotechnology & Medical Research

End-of-day quote Euronext Bruxelles
-	-

23/09	Lakefront Biotherapeutics' Gamgertamig Has Meaningful Opportunity in Rare Autoimmune Diseases, RBC Says	MT
23/09	RBC Upgrades Lakefront Biotherapeutics to Outperform From Sector Perform, Adds Speculative Risk, Raises Price Target to $45 From $26	MT

Upcoming events on Galapagos NV

11/11/2026	Earnings release - Q3 2026
13/11/2026	Earnings presentation

Past events on Galapagos NV

11/08/2026	Earnings presentation
10/08/2026	Earnings release - Q2 2026
07/05/2026	Earnings presentation	05:30 pm
06/05/2026	Earnings release - Q1 2026
28/04/2026	Annual General Meeting	05:30 pm
28/04/2026	Extraordinary General Meeting	06:30 pm
24/02/2026	Earnings presentation	06:30 pm
23/02/2026	Earnings release - Annual 2025
06/11/2025	Earnings presentation	06:30 pm
05/11/2025	Earnings release - Q3 2025

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million EUR	Released Forecast Spread	784 550 42.49%	276 309 -10.82%	1 112 280 297.2%	117	41,9	29,5
EBITDA Million EUR	Released Forecast Spread	0,00 -213 -	-153 -57,1 -167.99%	351 -364 196.41%	-132	-202	-284
EBIT Million EUR	Released Forecast Spread	129 -148 187.11%	-188 -133 -41.58%	295 -383 177.08%	-172	-222	-286
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	5,63 8,44 -33.34%	-3,09 -48,1 93.59%	301 -395 176.13%	-46,2	-194	-256
Net income Million EUR	Released Forecast Spread	212 -52,8 500.82%	74,1 -10,8 784.74%	321 -308 204.19%	-40,7	-213	-316
EPS EUR	Released Forecast Spread	3,21 -1,58 302.72%	1,12 -0,28 497.36%	4,87 -3,29 248.17%	-1,89	-4,66	-7,54
Announcement Date		22/02/24	12/02/25	23/02/26	-

Quarterly results

Fiscal Period	June	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2
Net sales Million EUR	Released Forecast Spread	75,5 69,9 8%	75,0 68,9 8.87%	65,3 70,5 -7.43%	71,2 69,1 3.01%	901 71,3 1162.61%	6,48 24,9 -73.97%	12,1 6,13 97.55%	41,2	107	6,95	6,95	6,95	6,95	7,01	7,01
EBITDA Million EUR	Released Forecast Spread	5,24							-30,0	6,05
EBIT Million EUR	Released Forecast Spread	-62,7 -33,7 -86.25%	-159 -35,6 -345.53%	-57,0 -33,5 -70.09%	-246 -33,5 -635.46%	757 -21,4 3642.73%	-63,7 -96,1 33.7%	-43,5 -794 94.52%	-32,6	-14,8	-44,6	-44,7	-45,0	-45,2	-46,5	-46,7
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	19,0 -37,9 150.18%	-156 -15,6 -899.75%	-104 -13,6 -667.4%	-221 -27,7 -698.6%	783 -9,27 8545.24%	14,0 -76,2 118.31%	2,01 -763 100.26%	-9,60	-52,4	-32,3	-32,7	-33,5	-34,1	-34,8	-35,3
Net income Million EUR	Released Forecast Spread	25,3 -50,3 150.36%	-153 -13,7 -1022.64%	-106 -13,6 -677.13%	-202 -19,6 -931.38%	782 85,3 816.5%	14,5 -73,1 119.83%	2,11 -758 100.28%	-7,10	-50,2	-27,3	-27,7	-28,5	-29,1	-29,8	-30,3
EPS EUR	Released Forecast Spread	0,38 -2,33 116.31%	-2,33 -0,19 -1097.2%	-1,60 -0,09 -1719.01%	-3,07 -0,23 -1236.29%	11,9 5,54 114.64%	0,22 -0,51 143.55%	0,03	-0,43	-1,70
Announcement Date		12/02/25	23/04/25	23/07/25	05/11/25	23/02/26	06/05/26	10/08/26	-	-	-	-	-	-	-	-

Upcoming sector events for Galapagos NV

06/10/2026	OMNIAB, INC.	Analyst/Investor Day	08:30 pm
07/10/2026	BASILEA PHARMACEUTICA AG	Information meeting
13/10/2026	LONZA GROUP AG	Analyst/Investor Day
13/10/2026	BIDE PHARMATECH CO., LTD.	Extraordinary General Meeting	07:30 am
14/10/2026	LONZA GROUP AG	Analyst/Investor Day	09:30 pm
14/10/2026	GEMPHARMATECH CO., LTD.	Earnings presentation	07:30 am
19/10/2026	GEMPHARMATECH CO., LTD.	Extraordinary General Meeting	07:30 am
20/10/2026	ARCUS BIOSCIENCES, INC.	Information meeting	06:00 pm
21/10/2026	4D MOLECULAR THERAPEUTICS, INC.	Analyst/Investor Day
22/10/2026	MEDPACE HOLDINGS, INC.	Earnings release - Q3 2026

Past sector events for Galapagos NV

01/10/2026	MONTE ROSA THERAPEUTICS, INC.	Information meeting	05:30 pm
30/09/2026	ADLAI NORTYE GROUP LTD.	Extraordinary General Meeting	07:30 am
30/09/2026	JADE BIOSCIENCES, INC.	Information meeting	06:00 pm
29/09/2026	GENFIT	Earnings release - Q2 2026
28/09/2026	SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.	Extraordinary General Meeting	12:00 pm
28/09/2026	R&G PHARMASTUDIES CO., LTD.	Extraordinary General Meeting	12:00 pm
24/09/2026	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	Analyst/Investor Day	06:30 pm
24/09/2026	ACADIA PHARMACEUTICALS INC.	Information meeting	05:30 pm
23/09/2026	BIO-TECHNE CORPORATION	Extraordinary General Meeting	06:30 pm
23/09/2026	BIO-TECHNE CORPORATION	Présentation aux Actionnaires / Analystes	06:30 pm

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

The best tools reserved for subscribers to boost the performance of your investments!